ATE498394T1 - Verfahren zur herstellung eines medikaments - Google Patents

Verfahren zur herstellung eines medikaments

Info

Publication number
ATE498394T1
ATE498394T1 AT04782768T AT04782768T ATE498394T1 AT E498394 T1 ATE498394 T1 AT E498394T1 AT 04782768 T AT04782768 T AT 04782768T AT 04782768 T AT04782768 T AT 04782768T AT E498394 T1 ATE498394 T1 AT E498394T1
Authority
AT
Austria
Prior art keywords
agglomerate
active ingredient
primary particles
carrier
particle size
Prior art date
Application number
AT04782768T
Other languages
English (en)
Inventor
Zeng Xian-Ming
Kee Tee Sean
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34272843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE498394(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ATE498394T1 publication Critical patent/ATE498394T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT04782768T 2003-09-02 2004-09-01 Verfahren zur herstellung eines medikaments ATE498394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49958203P 2003-09-02 2003-09-02
PCT/US2004/028345 WO2005020963A1 (en) 2003-09-02 2004-09-01 Process for preparing a medicament

Publications (1)

Publication Number Publication Date
ATE498394T1 true ATE498394T1 (de) 2011-03-15

Family

ID=34272843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04782768T ATE498394T1 (de) 2003-09-02 2004-09-01 Verfahren zur herstellung eines medikaments

Country Status (12)

Country Link
US (3) US9345664B2 (de)
EP (1) EP1699434B1 (de)
AT (1) ATE498394T1 (de)
CA (1) CA2575957C (de)
CY (1) CY1113221T1 (de)
DE (1) DE602004031459D1 (de)
DK (1) DK1699434T3 (de)
ES (1) ES2362038T3 (de)
PL (1) PL1699434T3 (de)
PT (1) PT1699434E (de)
SI (1) SI1699434T1 (de)
WO (1) WO2005020963A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ538965A (en) * 2002-08-21 2006-11-30 Norton Healthcare Ltd Dry powder inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20090246281A1 (en) * 2003-11-03 2009-10-01 Norton Healthcare Ltd. Soft steroid compositions for use in dry powder inhalers
EP1855689A1 (de) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmazeutische zusammensetzungen mit anticholinergika und etiprednol

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
IS1796B (is) 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
SE9400335D0 (sv) 1994-02-02 1994-02-02 Astra Ab Powder mixing
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
HUP9901575A3 (en) * 1996-04-29 1999-11-29 Dura Pharmaceuticals Inc San D Methods of dry powder inhalation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
DE10043509A1 (de) * 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
US8337816B2 (en) 2001-09-17 2012-12-25 Glaxo Group Limited Dry powder medicament formulations
US20050158248A1 (en) 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
NZ538965A (en) 2002-08-21 2006-11-30 Norton Healthcare Ltd Dry powder inhalation compositions
GB0219512D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios

Also Published As

Publication number Publication date
DK1699434T3 (da) 2011-05-30
ES2362038T3 (es) 2011-06-27
US9345664B2 (en) 2016-05-24
US9616024B2 (en) 2017-04-11
PT1699434E (pt) 2011-05-03
US20080131518A1 (en) 2008-06-05
US9987229B2 (en) 2018-06-05
US20160235678A1 (en) 2016-08-18
EP1699434A1 (de) 2006-09-13
US20170172925A1 (en) 2017-06-22
WO2005020963A1 (en) 2005-03-10
CA2575957A1 (en) 2005-03-10
DE602004031459D1 (de) 2011-03-31
SI1699434T1 (sl) 2011-06-30
EP1699434A4 (de) 2009-04-29
CY1113221T1 (el) 2016-04-13
EP1699434B1 (de) 2011-02-16
CA2575957C (en) 2010-11-30
PL1699434T3 (pl) 2011-09-30

Similar Documents

Publication Publication Date Title
ATE179886T1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
ATE336231T1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
TW200720307A (en) Catalyst compositions comprising support materials having an improved particle-size distribution
EP2357045A3 (de) Verfahren zur Herstellung einer Elektrode
DE59209244D1 (de) Inhalationspulver und verfahren zu ihrer herstellung
MXPA03001181A (es) Productos de perlita expandida con distribucion controlada de tamano de particula.
BRPI0409962A (pt) co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente
ATE206067T1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
ATE449596T1 (de) Verfahren zur herstellung von mikropartikeln
ATE408401T1 (de) Granulat oder pulver zur herstellung von überzugs-und bindemitteln für arzneiformen
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
CA2534056A1 (en) Calcium carbonate granulation
DE69929439D1 (de) Polyakrylsäure-granulate mit gesteuerter freigabe und verfahren zu dessen herstellung
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
CA2455261A1 (en) Sprinkling method for preparing powder formulations
AU2001291627A1 (en) Sustained release particle dispersion
ATE293957T1 (de) Verfahren zur herstellung von inhalationspulvern
DE60141680D1 (de) Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
AU2002314972A1 (en) Compressible guaifenesin compositions and method for producing them
TW200722075A (en) Propofol-containing fat emulsion
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
WO2006030301A8 (en) Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers
WO2005058473A3 (en) Particulate materials
ATE534371T1 (de) Pharmazeutische zubereitungen und verfahren zu deren herstellung
DE60016962D1 (de) Verfahren zur herstellung eines pulvers aus einem elastischen material

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1699434

Country of ref document: EP